Suzhou Highfine Biotech Co Ltd (SZSE:301393) Share Price

Company Profile

Business description
Suzhou Highfine Biotech Co Ltd is a high-tech enterprise that provides characteristic raw materials for global pharmaceutical research and development and raw material drug production companies. The products are mainly used in the fields of peptide, nucleotide and pharmaceutical synthesis. The product range covers peptide synthesis reagents for characteristic amide bond formation, molecular building blocks, protein reagents, liposome and lipid nanoparticle pharmaceutical reagents, ionic liquids , PROTAC reagents and nucleotide reagents and other types.
Contact
No. 32 Hongxi Road
F-12 Standard Factory Building
High-tech Zone, Jiangsu Province
Suzhou215151
CHN
T: +86 51265399366
https://www.highfine.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
678

Recommended

Solid demand profile for global leader.

Lochlan Halloway, CFA | 02 June 2026

Morningstar launches research coverage of SpaceX.

Nicolas Owens | 01 June 2026

An Australian fuel shortage is becoming increasingly unlikely, a relief for ASX toll road operator.

Adrian Atkins | 01 June 2026

Index	Last price	Change	% Change
All Ordinaries	8,920.30	28.60	-0.32%
CAC 40	8,146.59	36.75	-0.45%
DAX 40	25,003.04	101.66	-0.40%
Dow JONES (US)	51,078.88	46.42	0.09%
FTSE 100	10,338.95	70.33	-0.68%
HKSE	25,658.14	259.96	1.02%
NASDAQ	27,086.81	114.19	0.42%
Nikkei 225	65,833.49	1,100.84	-1.64%
NZX 50 Index	13,155.17	89.38	-0.67%
S&P 500	7,599.96	19.90	0.26%
S&P/ASX 200	8,682.10	24.60	-0.28%
SSE Composite Index	4,056.53	1.21	-0.03%